CHGCY
Price
$20.98
Change
-$0.91 (-4.16%)
Updated
Sep 26 closing price
Capitalization
69.54B
DSKYF
Price
$22.27
Change
+$0.17 (+0.77%)
Updated
Sep 26 closing price
Capitalization
41.91B
Interact to see
Advertisement

CHGCY vs DSKYF

Header iconCHGCY vs DSKYF Comparison
Open Charts CHGCY vs DSKYFBanner chart's image
Chugai Pharmaceutical
Price$20.98
Change-$0.91 (-4.16%)
Volume$184K
Capitalization69.54B
Daiichi Sankyo
Price$22.27
Change+$0.17 (+0.77%)
Volume$10.9K
Capitalization41.91B
CHGCY vs DSKYF Comparison Chart in %
Loading...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCY vs. DSKYF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCY is a Hold and DSKYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CHGCY: $20.98 vs. DSKYF: $22.27)
Brand notoriety: CHGCY and DSKYF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCY: 108% vs. DSKYF: 59%
Market capitalization -- CHGCY: $69.54B vs. DSKYF: $41.91B
CHGCY [@Pharmaceuticals: Major] is valued at $69.54B. DSKYF’s [@Pharmaceuticals: Major] market capitalization is $41.91B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCY’s FA Score shows that 1 FA rating(s) are green whileDSKYF’s FA Score has 1 green FA rating(s).

  • CHGCY’s FA Score: 1 green, 4 red.
  • DSKYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHGCY is a better buy in the long-term than DSKYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCY’s TA Score shows that 5 TA indicator(s) are bullish while DSKYF’s TA Score has 3 bullish TA indicator(s).

  • CHGCY’s TA Score: 5 bullish, 6 bearish.
  • DSKYF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CHGCY is a better buy in the short-term than DSKYF.

Price Growth

CHGCY (@Pharmaceuticals: Major) experienced а -9.26% price change this week, while DSKYF (@Pharmaceuticals: Major) price change was -3.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.20%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +12.50%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCY($69.5B) has a higher market cap than DSKYF($41.9B). CHGCY has higher P/E ratio than DSKYF: CHGCY (25.98) vs DSKYF (21.26). CHGCY YTD gains are higher at: -4.506 vs. DSKYF (-16.259). CHGCY has higher annual earnings (EBITDA): 556B vs. DSKYF (405B). CHGCY has more cash in the bank: 1.03T vs. DSKYF (848B). DSKYF has higher revenues than CHGCY: DSKYF (1.76T) vs CHGCY (1.2T).
CHGCYDSKYFCHGCY / DSKYF
Capitalization69.5B41.9B166%
EBITDA556B405B137%
Gain YTD-4.506-16.25928%
P/E Ratio25.9821.26122%
Revenue1.2T1.76T68%
Total Cash1.03T848B121%
Total DebtN/A102B-
FUNDAMENTALS RATINGS
CHGCY vs DSKYF: Fundamental Ratings
CHGCY
DSKYF
OUTLOOK RATING
1..100
644
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
993
PRICE GROWTH RATING
1..100
6279
P/E GROWTH RATING
1..100
7592
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHGCY's Valuation (24) in the null industry is somewhat better than the same rating for DSKYF (82). This means that CHGCY’s stock grew somewhat faster than DSKYF’s over the last 12 months.

CHGCY's Profit vs Risk Rating (100) in the null industry is in the same range as DSKYF (100). This means that CHGCY’s stock grew similarly to DSKYF’s over the last 12 months.

DSKYF's SMR Rating (3) in the null industry is significantly better than the same rating for CHGCY (99). This means that DSKYF’s stock grew significantly faster than CHGCY’s over the last 12 months.

CHGCY's Price Growth Rating (62) in the null industry is in the same range as DSKYF (79). This means that CHGCY’s stock grew similarly to DSKYF’s over the last 12 months.

CHGCY's P/E Growth Rating (75) in the null industry is in the same range as DSKYF (92). This means that CHGCY’s stock grew similarly to DSKYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCYDSKYF
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TECX15.200.49
+3.33%
Tectonic Therapeutic Inc.
CLF12.370.30
+2.49%
Cleveland-Cliffs
KLAC1064.295.19
+0.49%
KLA Corp
NAVI12.83-0.02
-0.16%
Navient Corp
CCEL4.80-0.05
-1.03%
Cryo-Cell International

CHGCY and

Correlation & Price change

A.I.dvisor tells us that CHGCY and CHGCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCY and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
-4.16%
CHGCF - CHGCY
32%
Poorly correlated
+6.60%
OTSKY - CHGCY
30%
Poorly correlated
-2.51%
OPHLY - CHGCY
22%
Poorly correlated
+1.60%
DSNKY - CHGCY
22%
Poorly correlated
-1.06%
RHHBY - CHGCY
20%
Poorly correlated
-0.93%
More

DSKYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSKYF has been loosely correlated with DSNKY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DSKYF jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSKYF
1D Price
Change %
DSKYF100%
+0.79%
DSNKY - DSKYF
43%
Loosely correlated
-1.06%
CHGCY - DSKYF
8%
Poorly correlated
-4.16%
CHJTF - DSKYF
8%
Poorly correlated
N/A
CSPCY - DSKYF
6%
Poorly correlated
-1.06%
GIFLF - DSKYF
6%
Poorly correlated
N/A
More